Key Takeaways Tempus AI acquired Paige for $81.25M, gaining 7M pathology images and FDA-cleared AI tools.The Deep 6 AI deal expanded Tempus' reach to 30M patient records across 750 healthcare providers.Ambry Genetics' acquisition broadened Tempus' AI-driven offerings into genetics and multiple specialties.Last Friday, Tempus AI, Inc. (TEM) announced the acquisition of Paige, an AI company specializing in digital pathology. The acquisition, valued at $81.25 million, is expected to allow Tempus to grow its da ...